Maria Fernanda de Castro-Amarante

7PUBLICATIONS
28CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapySequence analysisVeterinary diagnosis and diagnosticsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 27, 2025
T-Cell Epitope-Based SARS-CoV-2 DNA Vaccine Encoding an Antigen Fused with Type 1 Herpes Simplex Virus Glycoprotein D (gD).

Luana Raposo de Melo Moraes Aps, Aléxia Adrianne Venceslau-Carvalho, Carla Longo de Freitas

|Apr 27, 2024
Enhanced Immunogenicity and Protective Effects against SARS-CoV-2 Following Immunization with a Recombinant RBD-IgG Chimeric Protein.

Mariângela de Oliveira Silva, Maria Fernanda Castro-Amarante, Alexia Adrianne Venceslau-Carvalho

|Sep 28, 2023
Multi-epitope Antigen for Specific Serological Detection of Dengue Viruses.

Samuel Santos Pereira, Robert Andreata-Santos, Maria Fernanda de Castro-Amarante

|Apr 28, 2023
The Anti-Dengue Virus Peptide DV2 Inhibits Zika Virus Both In Vitro and In Vivo.

Maria Fernanda de Castro-Amarante, Samuel Santos Pereira, Lennon Ramos Pereira

|Oct 06, 2020
Intradermal Delivery of Dendritic Cell-Targeting Chimeric mAbs Genetically Fused to Type 2 Dengue Virus Nonstructural Protein 1.

Lennon Ramos Pereira, Elaine Cristina Matos Vicentin, Sara Araujo Pereira

Pageof 2